- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Sareum Share News (SAR)
Share News for Sareum (SAR)
| Share Price: 0.95 | Bid: 0.85 | Ask: 1.00 | Change: 0.025 (+2.70%) |  | ||||||
| ||||||||||
Sareum Holdings sells substantially all of Sareum Ltd. equipment assets
Tue, 26th Aug 2008 08:27
LONDON (Thomson Financial) - Sareum Holdings Plc. said it has sold substantially all of the eq
The drug discovery business said the structure-based drug discovery service business has been sold to Galapagos NV for 553,000 pounds cash. Under the terms of this agreement, Galapagos NV has acquired equipment assets and Sareum's ongoing service contracts.
The company said if this disposal had not been completed, Sareum Ltd. would have been unable to meet its financial commitments as they fell due and consequently would have been unable to continue trading resulting in the appointment of liquidators or administrators.
The company has retained the intellectual property of its cancer drug discovery programmes which it plans to develop using the proceeds of the disposal.
The company's shares will remain suspended while it completes its re-organisation and finalises its financial and business strategy.
TFN.newsdesk@thomson.com
ypv/ak
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
LONDON (Thomson Financial) - Sareum Holdings Plc. said it has sold substantially all of the eq
uipment assets of its wholly owned subsidiary Sareum Ltd. for 720,000 pounds in cash.
The drug discovery business said the structure-based drug discovery service business has been sold to Galapagos NV for 553,000 pounds cash. Under the terms of this agreement, Galapagos NV has acquired equipment assets and Sareum's ongoing service contracts.
The company said if this disposal had not been completed, Sareum Ltd. would have been unable to meet its financial commitments as they fell due and consequently would have been unable to continue trading resulting in the appointment of liquidators or administrators.
The company has retained the intellectual property of its cancer drug discovery programmes which it plans to develop using the proceeds of the disposal.
The company's shares will remain suspended while it completes its re-organisation and finalises its financial and business strategy.
TFN.newsdesk@thomson.com
ypv/ak
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
BRIEF-Sareum Holdings says not in discussions with AstraZeneca
LONDON, Nov 6 (Reuters) - Sareum Holdings PLC: * Sareum Holdings Plc : statement re share price movement * Not in discussions with Ast[6 Nov '12]
BRIEF-Physiomics comments on share price movement
LONDON, Aug 7 (Reuters) - Physiomics PLC: * Stmnt re share price movement * There are no agreements in existence between sareum,physio[7 Aug '12]
BRIEF-Sareum confirms negotiations with potential licencing partner
LONDON, Aug 7 (Reuters) - Sareum Holdings PLC: * Stmnt re share price movement * Can confirm that advanced stages of negotiations are[7 Aug '12]
UPDATE 1-Sareum soars on positive cancer drug results
LONDON, March 4 (Reuters) - Drug discovery firm Sareum Holdings said its cancer growth inhibitor therapy had showed positive results in pre-clin[4 Mar '11]
BRIEF-Sareum says colon cancer study results positive
LONDON, March 4 (Reuters) - Sareum Holdings PLC: * Positive results from pre-clinical in-vivo efficacy studies * Results demonstrate a[4 Mar '11]
STOCKS NEWS UK-Small cap pharmas buoyed by Sareum
STOCKS NEWS Reuters Europe Real-time Equity News UK Stocks on the[9 Feb '11]
BRIEF-Sareum says not currently in licensing talks
LONDON, Feb 9 (Reuters) - Sareum Holdings PLC: * Noted the recent significant rise in the company's share price * Is not currently in[9 Feb '11]
BRIEF-Sareum says knows no reason for share price rise
LONDON, Aug 28 (Reuters) - Sareum Holdings Plc: * Not aware of any reason behind the share price movement ((London Equities Newsroom;[28 Aug '09]
